Articles with "afatinib korean" as a keyword



Photo by djuls from unsplash

A real-world experience of first-line afatinib in Korean patients with EGFR-mutant non-small cell lung cancer

Sign Up to like & get
recommendations!
Published in 2019 at "Annals of Oncology"

DOI: 10.1093/annonc/mdz437.011

Abstract: Abstract Background Afatinib is indicated for the treatment of EGFR mutation-positive (M+) non-small cell lung cancer (NSCLC). LUX-Lung trials have demonstrated that afatinib significantly improved progression-free survival (PFS) compared with chemotherapy. We report results from… read more here.

Keywords: afatinib korean; first line; line afatinib; korean patients ... See more keywords